Michail V Sitkovsky

This inventor holds 11 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Northeastern University, The United States of America as Represented by the Department of Health. Active years: 1993-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michail V Sitkovsky. Retrieved from https://idiyas.com/inventor/michail-v-sitkovsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 6)

% Patents Active = 72.7

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 112(Granted Patents)

Location History:

Bethesda, MD (US) (1993 - 2014)
Boston, MA (US) (2010 - 2022)

Company Filing History:

4 out of 3,705

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

3 out of 691

Northeastern University

patents

1 out of 1,217

The United States of America as Represented by the Department of Health

patents

4. 1 out of 2

The United States of America as Represented by the Secretary of the Department of

patents

5. 1 out of 16,292

USA as Represented by Secretary of the Navy

patents

6. 1 out of 834,659

Other

patents

Years Active: 1993-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12303618 - Oxygen-generating cryogels (2025-05-20),

2. 11471528 - Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation (2022-10-18),

3. 10314908 - Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation (2019-06-11),

4. 9782428 - Method for generation of broadly neutralizing anti-pathogen antibodies (2017-10-10),

5. 9415105 - Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation (2016-08-16),

6. 8883500 - Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy (2014-11-11),

7. 8716301 - Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation (2014-05-06),

8. 8455437 - Method to predict and prevent oxygen-induced inflammatory tissue injury (2013-06-04),

9. 8080554 - Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation (2011-12-20),

10. 7718624 - Modulation of immune response and inflammation by targeting hypoxia inducible factors (2010-05-18),

11. 5180662 - Cytotoxic T lymphocyte activation assay (1993-01-19),

Title: The Innovative Mind of Michail V Sitkovsky

Introduction: Michail V Sitkovsky is a renowned inventor based in Boston, MA, known for his groundbreaking contributions to the field of biomedical research and immunology.

Latest Patents: Sitkovsky holds several patents related to immunotherapy and cancer treatment, showcasing his dedication to improving healthcare outcomes through innovative solutions.

Career Highlights: With a distinguished career spanning several decades, Sitkovsky has held key positions at prestigious research institutions and universities, where he has led pioneering studies on the immune system and inflammation.

Collaborations: Throughout his career, Sitkovsky has collaborated with leading scientists, medical professionals, and pharmaceutical companies to further the development of novel therapies and treatment approaches in the healthcare industry.

Conclusion: Michail V Sitkovsky's relentless pursuit of innovation and his commitment to advancing medical science have solidified his reputation as a trailblazing inventor in the field of immunology.

Profile summary based on public USPTO records.